Home/Pipeline/ANDAs Portfolio (Complex Generics)

ANDAs Portfolio (Complex Generics)

Various (Cardiology, CNS, etc.)

FDA Review / ApprovedActiveN/A

Key Facts

Indication
Various (Cardiology, CNS, etc.)
Phase
FDA Review / Approved
Status
Active
Company

About Alkem Laboratories

Founded in 1973, Alkem Laboratories has grown from a domestic manufacturer into a globally recognized pharmaceutical company with a mission to deliver trusted, affordable healthcare through innovation and quality. Its strategic pillars include a deep focus on complex generics and novel drug delivery systems, a sprawling international footprint, and a diversified portfolio across key therapeutic areas like anti-infectives, cardiology, and gastroenterology. The company's success is underpinned by its aggressive patent challenge strategy in regulated markets like the US, a vast network of 18 manufacturing facilities, and a strong commercial engine driving growth in both emerging and developed markets.

View full company profile